KFSH&RC Leads Global Healthcare Revolution with AI and Robotics
June 27 2024 - 8:00AM
KFSH&RC Leads Global Healthcare Revolution with AI and
Robotics
King Faisal Specialist Hospital & Research Centre (KFSH&RC)
is at the forefront of the global AI and robotics revolution. These
technological advancements, driven by Saudi Vision 2030, are set to
unlock an estimated $15 billion to $27 billion in economic value
for the Kingdom’s medical sector by 2030, in addition to their
pivotal role in streamlining processes and transforming patient
care.
Robotic-assisted surgeries are a hallmark of
KFSH&RC's technological integration. In 2023 alone, KFSH&RC
performed 1,195 robotic-assisted procedures, most notably, the
world’s first fully robotic liver transplantation, highlighting
KFSH&RC's pioneering role in using robotics to enhance surgical
precision and patient recovery.
Complementing these surgical advancements, Whole
Genome Sequencing (WGS), has become a cornerstone of KFSH&RC’s
approach to early detection and treatment of genetic disorders. By
conducting over 7,000 WGS tests in 2023 to date, the hospital has
enabled the identification of genetic predispositions to various
diseases. This dual focus on cutting-edge surgical technology and
comprehensive genetic analysis positions KFSH&RC at the
forefront of medical innovation, ensuring that patients receive the
most precise and effective care possible.
KFSH&RC's laboratories are also equipped
with automated systems that streamline diagnostics and testing
processes. These systems enhance accuracy and speed, allowing for
quicker diagnosis and treatment of patients. Over 1.5 million tests
were processed, reducing turnaround times by 30%.
Recognizing the transformative potential of
digital health, KFSH&RC has embraced AI-driven solutions across
various departments. In 2023, AI tools in radiology improved
diagnostic accuracy by 25% and reduced misdiagnosis rates by 18%,
enhancing the detection and treatment of diseases such as cancer
and cardiovascular disorders. By leveraging AI and advanced
biotechnological methods, KFSH&RC successfully produced CAR-T
cells internally for cancer treatment, reducing the cost of
treatment and alleviating patient suffering.
Central to KFSH&RC’s advancements is its
state-of-the-art Capacity Command Centre, the primary source for
data-driven decision-making. It monitors patient movements to
maintain care quality, adhere to standard procedures, and predict
demand volumes to mitigate risks. Utilizing AI-driven strategies,
the Centre has executed over 170,000 intervention procedures since
its launch in September 2021, reducing bed waiting times from 32
hours to 6 hours and cutting emergency department waiting times by
14%.
Looking ahead, KFSH&RC continues to
integrate advanced technologies into the global healthcare
ecosystem as a smart hospital and remains committed to driving
innovation and excellence in medical care.
It is noteworthy that KFSH&RC has been
ranked first in the Middle East and Africa and 20th globally, in
the list of the world’s top 250 Academic Medical Centres for the
second consecutive year and recognized as the most valuable
healthcare brand in the Kingdom and the Middle East, according to
the 2024 Brand Finance rankings. Additionally in the same year, it
was ranked among the world's best 250 hospitals by Newsweek
magazine.
For further information, please
contact:Mr. Essam AlZahrani, Acting Head of Media Affairs,
0555254429Mr. Abdullah Alown, Media Coordination Officer,
0556294232
Photo
available: https://www.globenewswire.com/NewsRoom/AttachmentNg/16594984-1eaf-488b-ada2-1291d75bf71c